TCG Crossover Management, LLC
Top Portfolio Positions
49 positions ·
$3,501,388,578 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| ABVX |
Abivax S.A.
Healthcare
|
6,481,085 | $721,668,814 | 20.61% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
3,670,206 | $248,399,542 | 7.09% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
10,531,071 | $220,310,005 | 6.29% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
4,946,894 | $190,405,950 | 5.44% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
4,286,480 | $170,258,985 | 4.86% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
1,676,624 | $140,702,286 | 4.02% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
3,248,980 | $124,435,934 | 3.55% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
4,457,988 | $110,736,421 | 3.16% | |
| BCRX |
Biocryst Pharmaceuticals Inc
Healthcare
|
11,020,968 | $104,919,615 | 3.00% | |
| VOR |
Vor Biopharma Inc.
Healthcare
|
5,673,078 | $101,207,711 | 2.89% |
Portfolio Trend
18 quarters · across all stocks
Holdings in ABVX
Shares Held
Position Value (USD)
10 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $721,668,814 | 6,481,085 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $959,034,278 | 7,111,596 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $603,774,500 | 7,111,596 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $46,332,959 | 6,056,596 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $37,853,725 | 6,056,596 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $44,334,282 | 6,056,596 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $69,771,985 | 6,056,596 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $80,068,199 | 6,056,596 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $15,730,000 | 1,100,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $11,770,000 | 1,100,000 | Shares | Sole | 2024-02-14 | |
| No 13F history on record for this holder in this stock. | ||||||